PapersFlow Research Brief
NF-κB Signaling Pathways
Research Guide
What is NF-κB Signaling Pathways?
NF-κB signaling pathways are inducible transcription factor systems composed of Rel family proteins that regulate genes involved in inflammation, immunity, and cancer through mechanisms including IκB degradation, phosphorylation, and ubiquitination.
NF-κB signaling pathways control a wide range of genes in response to stimuli like TNF-α and LPS, activating processes in inflammation and immunity. The field includes 31,922 works examining regulation of NF-κB activity and its crosstalk with pathways like TLR and MAP kinase signaling. These pathways link innate immune responses to disease states such as cancer progression.
Topic Hierarchy
Research Sub-Topics
NF-κB Regulation by Ubiquitination and IKK
Researchers investigate IκB kinase activation, ubiquitination of pathway components, and phosphorylation controls. Mechanistic studies elucidate feedback loops in NF-κB activation.
NF-κB in Inflammatory Diseases
This sub-topic covers NF-κB's role in chronic inflammation, linking TLR signaling and TNF-α to conditions like arthritis. Studies explore therapeutic inhibition strategies.
NF-κB Signaling in Cancer Development
Research examines NF-κB's promotion of tumor survival, proliferation, and metastasis via gene regulation. Analyses include crosstalk with oncogenes and tumor microenvironment.
NF-κB and Innate Immunity
Studies focus on Toll-like receptor pathways activating NF-κB for antimicrobial responses. Research addresses defects in models like C3H/HeJ mice.
Crosstalk Between NF-κB and Other Signaling Pathways
This area explores integrations with MAPK, apoptosis, and Rel protein networks. Investigations reveal pathway convergence in immunity and stress responses.
Why It Matters
NF-κB signaling pathways drive inflammation and cancer development, with therapeutic targeting explored for diseases involving excessive activation. Liu et al. (2017) in "NF-κB signaling in inflammation" detail how NF-κB coordinates cytokine and adhesion molecule expression, contributing to chronic inflammatory conditions. Karin and Ben-Neriah (2000) in "Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity" explain regulation via IKK-mediated phosphorylation and ubiquitination of IκB, offering targets for inhibitors in cancer therapy where NF-κB promotes cell survival. Ghosh et al. (1998) in "NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses" highlight NF-κB's role in immune cell activation, with implications for immunotherapy.
Reading Guide
Where to Start
"NF-κB signaling in inflammation" by Liu et al. (2017) provides a focused entry on core mechanisms linking NF-κB to inflammation and disease, ideal before broader reviews.
Key Papers Explained
Liu et al. (2017) "NF-κB signaling in inflammation" builds on foundational regulation from Baldwin (1996) "THE NF-κB AND IκB PROTEINS: New Discoveries and Insights" and Ghosh et al. (1998) "NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses" by integrating modern insights into inflammation. Karin and Ben-Neriah (2000) "Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity" extends these with mechanistic details on IKK and ubiquitination, while Takeda et al. (2003) "Toll-Like Receptors" connects upstream TLR inputs to NF-κB outputs described earlier.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research extends canonical regulation to cancer contexts, with papers like Poltorak et al. (1998) on Tlr4 mutations informing genetic models of pathway defects, though no preprints or news in the last 12 months indicate steady maturation without major shifts.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | NF-κB signaling in inflammation | 2017 | Signal Transduction an... | 7.7K | ✓ |
| 2 | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Muta... | 1998 | Science | 7.5K | ✕ |
| 3 | Toll-Like Receptors | 2003 | Annual Review of Immun... | 6.1K | ✕ |
| 4 | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, t... | 1993 | Cell | 6.0K | ✕ |
| 5 | THE NF-κB AND IκB PROTEINS: New Discoveries and Insights | 1996 | Annual Review of Immun... | 5.9K | ✕ |
| 6 | NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of ... | 1998 | Annual Review of Immun... | 5.2K | ✕ |
| 7 | Mammalian MAP kinase signalling cascades | 2001 | Nature | 5.1K | ✕ |
| 8 | Apoptosis by Death Factor | 1997 | Cell | 5.0K | ✓ |
| 9 | Toll-like receptors: critical proteins linking innate and acqu... | 2001 | Nature Immunology | 4.7K | ✕ |
| 10 | Phosphorylation Meets Ubiquitination: The Control of NF-κB Act... | 2000 | Annual Review of Immun... | 4.7K | ✕ |
Frequently Asked Questions
What regulates NF-κB activation?
NF-κB activation is primarily regulated by IκB proteins that sequester NF-κB in the cytoplasm, with IKK complex phosphorylating IκB for ubiquitination and degradation. Karin and Ben-Neriah (2000) in "Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity" describe this process enabling NF-κB nuclear translocation. Baldwin (1996) in "THE NF-κB AND IκB PROTEINS: New Discoveries and Insights" notes the complexity of NF-κB subunits and IκB interactions.
How does NF-κB function in inflammation?
NF-κB signaling induces proinflammatory cytokines and adhesion molecules upon stimulation by TNF-α or LPS. Liu et al. (2017) in "NF-κB signaling in inflammation" outline NF-κB's central role in coordinating inflammatory responses. This pathway connects innate immunity signals to gene expression driving inflammation.
What is the role of Toll-like receptors in NF-κB signaling?
Toll-like receptors (TLRs) detect microbial components like LPS and activate NF-κB via adaptor proteins, linking innate immunity to transcription. Takeda et al. (2003) in "Toll-Like Receptors" describe TLR signaling pathways including Toll and IMD in Drosophila that parallel mammalian NF-κB activation. Akira et al. (2001) in "Toll-like receptors: critical proteins linking innate and acquired immunity" emphasize TLRs bridging innate and adaptive responses through NF-κB.
How do mutations affect NF-κB-related signaling?
Mutations in Tlr4 impair LPS signaling and NF-κB activation, conferring endotoxin resistance but infection susceptibility. Poltorak et al. (1998) in "Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene" identify Lps^d allele missense mutations in C3H/HeJ mice disrupting this pathway. This demonstrates genetic control over NF-κB-mediated innate immunity.
What are key NF-κB subunits and their evolution?
NF-κB comprises Rel family proteins including p65/RelA, c-Rel, RelB, p50, and p52, conserved across species for immune responses. Ghosh et al. (1998) in "NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses" trace their role in cytokine expression. Baldwin (1996) in "THE NF-κB AND IκB PROTEINS: New Discoveries and Insights" discusses subunit diversity and regulation.
Open Research Questions
- ? How does crosstalk between NF-κB and MAP kinase pathways precisely integrate signals for cancer progression?
- ? What specific ubiquitination patterns distinguish canonical versus non-canonical NF-κB activation in immunity?
- ? How do TLR mutations beyond Tlr4 alter NF-κB responses to diverse pathogens?
- ? What mechanisms allow NF-κB to balance inflammation and cell death in tumor microenvironments?
- ? How does evolutionary conservation of Rel proteins influence therapeutic targeting across species?
Recent Trends
The field encompasses 31,922 works on NF-κB signaling in inflammation, immunity, and cancer, with high citation classics like Liu et al. "NF-κB signaling in inflammation" (7660 citations) and Poltorak et al. (1998) "Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene" (7539 citations) dominating, but no growth rate, recent preprints, or news coverage signals stable foundational research without acceleration.
2017Research NF-κB Signaling Pathways with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching NF-κB Signaling Pathways with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers